These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9607420)

  • 1. Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex.
    Imaoka T; Date I; Ohmoto T; Nagatsu T
    Hum Gene Ther; 1998 May; 9(7):1093-102. PubMed ID: 9607420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector.
    Sun M; Zhang GR; Kong L; Holmes C; Wang X; Zhang W; Goldstein DS; Geller AI
    Hum Gene Ther; 2003 Mar; 14(5):415-24. PubMed ID: 12691607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
    Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
    Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors.
    Fan DS; Ogawa M; Fujimoto KI; Ikeguchi K; Ogasawara Y; Urabe M; Nishizawa M; Nakano I; Yoshida M; Nagatsu I; Ichinose H; Nagatsu T; Kurtzman GJ; Ozawa K
    Hum Gene Ther; 1998 Nov; 9(17):2527-35. PubMed ID: 9853519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease].
    Lu LL; Su Y; Duan CL; Zhao CL; Su YJ; Wu J; Zhao HY; Xu QY; Yang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1528-32. PubMed ID: 15500713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease.
    Azzouz M; Martin-Rendon E; Barber RD; Mitrophanous KA; Carter EE; Rohll JB; Kingsman SM; Kingsman AJ; Mazarakis ND
    J Neurosci; 2002 Dec; 22(23):10302-12. PubMed ID: 12451130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
    Zhang Y; Calon F; Zhu C; Boado RJ; Pardridge WM
    Hum Gene Ther; 2003 Jan; 14(1):1-12. PubMed ID: 12573054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes.
    Muramatsu S; Fujimoto K; Ikeguchi K; Shizuma N; Kawasaki K; Ono F; Shen Y; Wang L; Mizukami H; Kume A; Matsumura M; Nagatsu I; Urano F; Ichinose H; Nagatsu T; Terao K; Nakano I; Ozawa K
    Hum Gene Ther; 2002 Feb; 13(3):345-54. PubMed ID: 11860702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
    Kaplitt MG; Leone P; Samulski RJ; Xiao X; Pfaff DW; O'Malley KL; During MJ
    Nat Genet; 1994 Oct; 8(2):148-54. PubMed ID: 7842013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism.
    Segovia J; Vergara P; Brenner M
    Gene Ther; 1998 Dec; 5(12):1650-5. PubMed ID: 10023444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of foreign tyrosine hydroxylase gene in the rat model of Parkinson's disease].
    Jiang ZH; Ni ZM; Zhou CF; Cao L; Zheng ZC; Liu XY; Zhao YC; Chen SD
    Sheng Li Xue Bao; 1997 Apr; 49(2):141-5. PubMed ID: 9812848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracerebral transplantation of genetically modified cells for Parkinson's disease].
    Tang Z; Ying Q; Peng L
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):10-2. PubMed ID: 10374498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotransduction of tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes into cultured striatal cells using adeno-associated virus vectors.
    Fan D; Kang D; Ogawa M; Nakano I; Nagatsu T; Kurtzman GJ; Ozawa K
    Chin Med J (Engl); 1998 Dec; 111(12):1111-3. PubMed ID: 11263376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
    Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracerebral grafting of ex vivo transgene muscle cells in rat model of parkinsonism].
    Xu Q; Tian J; Zhang J
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):5-9. PubMed ID: 10374497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
    Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
    Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
    Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.